These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Büchter D, Behre HM, Kliesch S, Nieschlag E. Eur J Endocrinol; 1998 Sep; 139(3):298-303. PubMed ID: 9758439 [Abstract] [Full Text] [Related]
11. [Induced changes of seminogram by use of HMG and HCG in patients with testicular anomalies and aspermia]. Esteban J, Portuondo JA, Belausteguigoitia FJ, Bilbao F. Acta Ginecol (Madr); 1975 Nov 01; 27(9):415-25. PubMed ID: 1217456 [No Abstract] [Full Text] [Related]
12. Assessment of deoxyribonucleic acid fragmentation index, testicular volume, semen parameters, and hormone profile in gonadotropin-treated men with hypogonadotropic hypogonadism. Hosseinifar H, Sabbaghian M, Chehrazi M, Modarresi T, Alipour FJ, Sadighi Gilani MA. Urology; 2013 Dec 01; 82(6):1291-5. PubMed ID: 24094652 [Abstract] [Full Text] [Related]
13. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism. Sinisi AA, Esposito D, Maione L, Quinto MC, Visconti D, De Bellis A, Bellastella A, Conzo G, Bellastella G. Hum Reprod; 2008 May 01; 23(5):1029-34. PubMed ID: 18343809 [Abstract] [Full Text] [Related]
14. Improvement of spermatogenesis by hCG and hMG treatment in pubertal boys with history of orchiopexy at early childhood. Okuyama A, Namiki M, Aono T, Matsumoto K, Utsunomiya M, Itoh H, Yoshioka T, Itatani H, Sonoda T. Arch Androl; 1984 May 01; 12 Suppl():29-33. PubMed ID: 6152576 [Abstract] [Full Text] [Related]
15. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Warne DW, Decosterd G, Okada H, Yano Y, Koide N, Howles CM. Fertil Steril; 2009 Aug 01; 92(2):594-604. PubMed ID: 18930225 [Abstract] [Full Text] [Related]
17. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis. Zacharin M, Sabin MA, Nair VV, Dabadghao P. Fertil Steril; 2012 Oct 01; 98(4):836-42. PubMed ID: 22763096 [Abstract] [Full Text] [Related]
18. Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadism. Kirk JM, Savage MO, Grant DB, Bouloux PM, Besser GM. Clin Endocrinol (Oxf); 1994 Jul 01; 41(1):57-63. PubMed ID: 7914153 [Abstract] [Full Text] [Related]
19. [The application of gonadotropin in treatment of male central hypogonadism]. Di FS, Cui YG, Jia Y. Zhonghua Nei Ke Za Zhi; 2005 Nov 01; 44(11):836-9. PubMed ID: 16316564 [Abstract] [Full Text] [Related]